Analytical Data
-
Gene name
Chi3l4
- Application
-
Alternative Names
Chitinase-3-like protein 4 Secreted protein Ym2
-
Species
Mouse
-
Source
Yeast
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q91Z98
-
Expression Region
22-402aa
-
Molecular Weight
44.9
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Chi3l4, also known as chitinase-3-like protein 4, is a member of the chitinase-like protein family, which plays a critical role in various biological processes, including inflammation, tissue remodeling, and immune response. Originally identified as an eosinophil-associated protein, Chi3l4 is primarily expressed in immune cells and is thought to participate in the regulation of allergic reactions and responses to parasitic infections. Recent studies have highlighted its role in several disease states, including asthma, cancer, and cardiovascular diseases, suggesting that Chi3l4 may serve as a potential biomarker for disease progression and a target for therapeutic intervention. The protein is believed to influence the immune landscape by modulating the activities of various immune cells, thereby affecting inflammation and tissue homeostasis. As research continues to unveil the functional implications of Chi3l4, understanding its expression patterns and mechanisms may provide insights into the development of targeted therapies for conditions where inflammation and immune dysregulation are pivotal. The focus on Chi3l4 in recent years underscores its significance in both basic and translational research, specifically in the context of its potential to inform the design of novel diagnostic and therapeutic strategies for immune-related diseases. Thus, the study of Chi3l4 recombinant proteins aims to elucidate their biological functions, therapeutic applications, and mechanisms of action, thereby contributing to the broader field of immunology and disease treatment strategies.
